Study likely spells end for anti-bleeding drug

An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.Bayer Antibleeding Drug Takes Hit Wall Street JournalAprotinin (Trasylol) Down But Not Totally Out MedPage TodayReuters - eFluxMedia - Washington Post - InjuryBoard.com